Depatuxizumab mafodotin Terminated Phase 2 Trials for Diffuse Large B-Cell Lymphoma (DLBCL) / B-Cell Lymphoma / Grade 3b Follicular Lymphoma Treatment

Indications	Status	Purpose	Phase
DBCOND0028221 (Diffuse Large B-Cell Lymphoma (DLBCL)) DBCOND0028340 (B-Cell Lymphoma) DBCOND0048830 (Grade 3b Follicular Lymphoma)	Terminated	Treatment	2

clinicaltrials.gov Identifier	Title	Drugs
NCT02592876	Treatment Study of Denintuzumab Mafodotin (SGN-CD19A) Plus RICE Versus RICE Alone for Diffuse Large B-Cell Lymphoma	Carboplatin (DB00958) Depatuxizumab mafodotin (DB11731) Etoposide (DB00773) Ifosfamide (DB01181) Rituximab (DB00073)